Trial achieved biological proof-of-concept, dose discovery and biomarker improvement. San Diego, California--(Newsfile Corp. - November 4, 2025) - Thiogenesis Therapeutics, Corp.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback